Biodexa Pharmaceuticals Plc Adr (BDRX)

Jun 18, 2025

Biodexa enrolls first patient in type 1 diabetes drug trial - Investing.com

Jun 18, 2025

Jun 13, 2025

Biodexa Pharmaceuticals changes share nominal value By Investing.com - Investing.com South Africa

Jun 13, 2025

Jun 13, 2025

Biodexa Pharmaceuticals changes share nominal value - Investing.com

Jun 13, 2025

Jun 11, 2025

Biodexa shareholders approve all resolutions at general meeting By Investing.com - Investing.com India

Jun 11, 2025

Jun 11, 2025

Biodexa shareholders approve all resolutions at general meeting - Investing.com

Jun 11, 2025

May 22, 2025

Biodexa secures additional $3M for cancer drug trial By Investing.com - Investing.com India

May 22, 2025

May 22, 2025

BDRXBiodexa Pharmaceuticals plc Latest Stock News & Market Updates - Stock Titan

May 22, 2025

May 22, 2025

Biodexa secures additional $3M for cancer drug trial - Investing.com

May 22, 2025

May 20, 2025

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Could Find a Support Soon, Here - sharewise

May 20, 2025

May 20, 2025

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Nasdaq

May 20, 2025

May 15, 2025

Biodexa Pharmaceuticals adjusts warrant exercise price - Investing.com

May 15, 2025

May 15, 2025

Biodexa Pharmaceuticals adjusts warrant exercise price By Investing.com - Investing.com India

May 15, 2025

May 12, 2025

Biodexa gains orphan drug status in EU for colon disease treatment - Investing.com

May 12, 2025

Apr 24, 2025

What Makes Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) a New Buy Stock - MSN

Apr 24, 2025

Mar 19, 2025

Biodexa Pharmaceuticals advances FAP treatment trial By Investing.com - Investing.com South Africa

Mar 19, 2025

Mar 19, 2025

Biodexa Pharmaceuticals advances FAP treatment trial - Investing.com India

Mar 19, 2025

Mar 19, 2025

With Fast Track Designation in Hand, a Successful Protocol Discussion with FDA, and CROs in Place, Biodexa is on Track to Initiate its Funded Phase 3 Trial in FAP Next Quarter - BioSpace

Mar 19, 2025

Mar 10, 2025

Biodexa gets FDA nod for Phase 3 eRapa study in FAP - Investing.com India

Mar 10, 2025

Mar 07, 2025

Why Plus Therapeutics, Inc. (PSTV) Soared on Thursday - Yahoo Finance

Mar 07, 2025

Mar 06, 2025

Biodexa selects Precision as CRO for eRapa Phase 3 study in Europe - Investing.com

Mar 06, 2025

Feb 12, 2025

Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status - Barchart

Feb 12, 2025

Feb 11, 2025

Biodexa Pharmaceuticals Plc ADR [BDRX] Is Currently 31.94 above its 200 Period Moving Avg: What Does This Mean? - The DBT News

Feb 11, 2025

Feb 10, 2025

why Teva- Pharmaceutical Industries Ltd. ADR [TEVA] is a Good Choice for Investors After New Price Target of $24.71 - The DBT News

Feb 10, 2025

Feb 10, 2025

Palantir Technologies Inc [PLTR] Is Currently -0.39 below its 200 Period Moving Avg: What Does This Mean? - The DBT News

Feb 10, 2025

Feb 10, 2025

Biodexa Pharmaceuticals Plc ADR (BDRX) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle

Feb 10, 2025

Feb 10, 2025

Hesai Group ADR (HSAI) Shares Up Despite Recent Market Volatility - The News Heater

Feb 10, 2025

Feb 10, 2025

Biodexa Pharmaceuticals Plc ADR (BDRX) vs. Its Peers: A Comparison - The News Heater

Feb 10, 2025

Feb 10, 2025

Omega Therapeutics Inc (OMGA) Stock: A SWOT Analysis - The News Heater

Feb 10, 2025

Feb 10, 2025

AES Corp (AES) Shares Down Despite Recent Market Volatility - The News Heater

Feb 10, 2025

Feb 10, 2025

Altus Power Inc (AMPS) vs. Its Peers: A Comparison - The News Heater

Feb 10, 2025

Jan 30, 2025

Skechers (SKX) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

Jan 30, 2025

Jan 30, 2025

Is Argenx (ARGX) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Jan 30, 2025

Jan 14, 2025

Are Medical Stocks Lagging Argenx (ARGX) This Year? - Yahoo Finance

Jan 14, 2025

Jan 03, 2025

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Moves to Buy: Rationale Behind the Upgrade - MSN

Jan 03, 2025

Nov 22, 2024

Result of General Meeting - GlobeNewswire

Nov 22, 2024

Nov 12, 2024

Biodexa Pharmaceuticals regains Nasdaq compliance - Investing.com

Nov 12, 2024

Oct 17, 2024

Biodexa reports promising glioblastoma trial results - Investing.com

Oct 17, 2024

Oct 15, 2024

Biodexa Announces Successful Appeal of Nasdaq Delisting - GlobeNewswire

Oct 15, 2024

Oct 04, 2024

Biodexa reports survival rates in glioblastoma study - Investing.com

Oct 04, 2024

Sep 19, 2024

ADR Ratio Change - Yahoo Finance

Sep 19, 2024

Jul 17, 2024

BDRX Stock Price and Chart — NASDAQ:BDRX - TradingView

Jul 17, 2024

Mar 01, 2024

PRFX Stock Quote Price and Forecast - CNN

Mar 01, 2024

Feb 09, 2024

symbol__ Stock Quote Price and Forecast - CNN

Feb 09, 2024

Dec 19, 2023

Why Biodexa Pharmaceuticals (BDRX) Shares Are Getting Hammered - TradingView

Dec 19, 2023

Jul 05, 2023

Biodexa Pharmaceuticals will rise 8,000% at the open - Dhaka Tribune

Jul 05, 2023

Jun 27, 2023

Biodexa Pharma (BDRX) Stock Rallied 27% on Investor Interest - AskTraders.com

Jun 27, 2023

Jun 23, 2023

Why Virgin Galactic Are Trading Lower By Around 18%; Here Are 20 Stocks Moving Premarket - markets.businessinsider.com

Jun 23, 2023

Mar 30, 2023

Biodexa Pharmaceuticals (BDRX) Stock Price, News & Analysis - MarketBeat

Mar 30, 2023

Mar 30, 2023

BDRX News Today | Why did Biodexa Pharmaceuticals stock go down today? - MarketBeat

Mar 30, 2023

Mar 28, 2023

Midatech PharmaDevelopment pipeline expands with MTD217 - research-tree.com

Mar 28, 2023

Jan 08, 2017

Biodexa Pharmaceuticals PLC DRC Stock Price Today | NASDAQ: BDRX Live - Investing.com

Jan 08, 2017

Sep 06, 2016

Midatech Is Something To Keep An Eye On (NASDAQ:BDRX) - Seeking Alpha

Sep 06, 2016

Jul 27, 2011

ADVFN | Live Stock, Options & Crypto Market Data, Trading Tools & Community - ADVFN

Jul 27, 2011